Taking Back Our Stolen History
WHO Gives Indoor Use of DDT a Clean Bill of Health for Controlling Malaria
WHO Gives Indoor Use of DDT a Clean Bill of Health for Controlling Malaria

WHO Gives Indoor Use of DDT a Clean Bill of Health for Controlling Malaria

The World Health Organization’s announcement Sept. 15 that it will back DDT spraying on the inside walls of houses to kill or repel malaria-carrying mosquitoes is very good news. The reversal of WHO’s 30-year policy against DDT brings the hope that the relentless disease, which now kills one African child every 30 seconds, can be brought under control. Malaria sickens and debilitates 500 million people a year, killing about 1 million of them; the majority of the dead are women and children on the African continent.

Indoor residual spraying, or IRS, involves spraying minute amounts of insecticides on the inside walls and roof of houses once or twice a year. DDT is the most effective of the approved insecticides. It is also long-lasting (it can be sprayed just once a year) and relatively inexpensive (about $5 per average five-person household). It either kills mosquitoes resting on the walls, or repels them from the dwelling. The malaria-bearing mosquitoes bite mostly at night.

For many African countries now debating the use of DDT, the WHO decision will be a lifesaver. Just days after the WHO announcement, Uganda said that it will go forward with its indoor spraying program in 2007. Uganda’s Health Ministry reported on Sept. 20 that spraying with DDT would help reduce infant mortality from the current 88 out of 1,000 births to 10. Opponents had complained that use of DDT will cut into their agricultural exports to the European Union, which is notoriously frightened of pesticides. Meanwhile, 800 Ugandan children die a day from malaria.

Studies have shown that malaria incidence drops dramatically after an indoor spraying campaign. South Africa, for example, resumed the use of DDT in 2003, and within one year, the incidence of malaria in the worst-hit province, KwaZulu Natal, fell by 80%. In two years, the number of malaria cases and deaths dropped by 93%. As the WHO has stressed, there are no environmental effects when small amounts of DDT are sprayed on inside house walls.

WHO’s Policy Turnabout

WHO appointed Dr. Arata Kochi as head of its Global Malaria Program in late 2005, with the task of assessing the WHO program and making proposals for its future work. Kochi was blunt in his criticism of WHO’s past effort and in what was needed to combat malaria. As he announced at a Washington, D.C. press conference Sept. 15, “We must take a position based on the science and the data.” Anticipating a reaction from a public brainwashed into demonizing DDT, he issued an appeal: “Help save African babies, as you help save the environment.”

The new WHO malaria campaign has three aims: 1) prompt and effective treatment of the infected; 2) indoor residual spraying, with DDT as the most effective insecticide of those allowed; and 3) the use of bednets treated with a long-lasting insecticide.

Dr. Pierre Guillet, a medical entomologist who coordinates the WHO Vector Control and Prevention Team, acknowledged in an interview with this reporter Sept. 21, that DDT had been out of the picture for many years, under pressure from environmentalists, who wanted an end to all pesticides. But the alternative approaches—such as “case management,” “integrated vector control,” and more recently, insecticide-treated bednets—did not work to control the spread of malaria. Guillet has spent 17 years working on malaria control, 10 in Africa, and the past 7 years at WHO headquarters in Geneva. He stressed that WHO’s policy now is to focus on areas of high malaria transmission to achieve at least 80% coverage of the population with indoor house spraying and bednets. “We need a very fast scale-up of these efforts,” Guillet said.

“The change that has been made by Dr. Kochi is to say that if we want to seriously talk about malaria control, we have to control transmission, and to do that we need high coverage. To reach high coverage, we have to use the interventions that we know are effective, which are IRS and long-lasting bednets. They are not exclusive … it is the combination of the the two with the main objective to scale up rapidly coverage, in order to be effective in terms of transmission control.”

Was the motivation for the ban on DDT at the WHO because of Malthusian views? Guillet said that he could not speak for the WHO as an institution. “For me, DDT is a non-issue. The issue is the intervention and the objective…. Today, we have to admit that DDT is the most effective and the cheapest insecticide. And when recognizing that, at a time when the genome of the parasite has been sequenced, and the genome of the major vector has been sequenced, still relying on a compound is more than 60 years old, and that has damaging effects when used indiscriminately, is a shame. And I see that, to a certain extent, as a failure of our international community to develop safe alternatives—not that DDT is not safe, but DDT is an emblematic product…. You cannot swim against the stream too long.”

Guillet noted that the Stockholm Convention on pesticides had put DDT on the phase-out list, but with no time limit imposed. “Fine,” he said, “but if we ban DDT right now, it will have more damaging effects on human health than using it….”

In response to my assertion that there had been no damage to human health from DDT, Guillet said that he wasn’t a toxicologist, but he agreed that “There is no direct evidence of toxic effects of DDT on human health.” If we haven’t found any such evidence after 60 years, “It is bloody safe,” he said. However, WHO will conduct studies on the effects of IRS on human health and will monitor potential side effects of DDT and other insecticides.

Guillet strongly recommended that an international partnership work on the development of new insecticides, and said that the Gates Foundation has begun to do this, to improve the formulation of current insecticides and their application in vector control.

A Deadly Ban

While the fine points of previous anti-malaria policies can be endlessly debated, the bottom line is that millions of people have died of malaria as a result of the ban on DDT, most of them in Africa. and hundreds of millions more have severely suffered from the disease.

DDT was banned in the United States in 1972 on the basis of a big lie, not science. In fact, the U.S. Environmental Protection Agency held seven months of hearings on the issue, producing 9,000 pages of testimony. The EPA hearing examiner, Edmund Sweeney, ruled, on the basis of the scientific evidence, that DDT should not be banned. “DDT is not carcinogenic, mutagenic, or teratogenic to man [and] these uses of DDT do not have a deleterious effect on fish, birds, wildlife, or estuarine organisms,” Sweeney concluded.

But two months later, without even reading the testimony or attending the hearings, EPA administrator William Ruckelshaus overruled the EPA hearing officer and banned DDT. He later admitted that he made the decision for “political” reasons.

Although other nations continued to DDT after 1972, the U.S. State Department mandated that no U.S. aid could go to any foreign program that made use of a pesticide banned in the United States. As a result, malaria rates in tropical countries began to climb, turning around DDT’s initial success in either eliminating or lessening the impact of the disease. Former Secretary of State George Shultz reinforced the State Department anti-DDT policy in a 1986 telegram to all U.S. embassies abroad. But in the last year, in response to Congressional hearings on the science, and pressure from constituent groups like the Congress for Racial Equality, the U.S. Agency for International Development did an about-face on DDT, permitting use of DDT.

DDT is not a panacea for malaria. Africa desperately requires economic development, including adequate public health programs and health infrastructure to keep malaria under control. This is not just a question of Africa or other tropical countries: In the rest of the world, including the industrialized West, the takedown of public health infrastructure has begun to leave even privileged populations vulnerable to insect-borne diseases. Policy has been determined by the views of those environmentalists who foolishly leave human health out of their schemes to protect a mythical Mother Nature—and mosquitoes are allowed to breed freely.

by Marjorie Mazel Hecht (LarouchePub)

The WHO Press Release:

<strong>WHO gives indoor use of DDT a clean bill of health for controlling malaria</strong>

WHO promotes indoor spraying with insecticides as one of three main interventions to fight malaria

Nearly thirty years after phasing out the widespread use of indoor spraying with DDT and other insecticides to control malaria, the World Health Organization (WHO) today announced that this intervention will once again play a major role in its efforts to fight the disease. WHO is now recommending the use of indoor residual spraying (IRS) not only in epidemic areas but also in areas with constant and high malaria transmission, including throughout Africa.

“The scientific and programmatic evidence clearly supports this reassessment,” said Dr Anarfi Asamoa-Baah, WHO Assistant Director-General for HIV/AIDS, TB and Malaria. “Indoor residual spraying is useful to quickly reduce the number of infections caused by malaria-carrying mosquitoes. IRS has proven to be just as cost effective as other malaria prevention measures, and DDT presents no health risk when used properly.”

WHO actively promoted indoor residual spraying for malaria control until the early 1980s when increased health and environmental concerns surrounding DDT caused the organization to stop promoting its use and to focus instead on other means of prevention. Extensive research and testing has since demonstrated that well-managed indoor residual spraying programmes using DDT pose no harm to wildlife or to humans.

“We must take a position based on the science and the data,” said Dr Arata Kochi, Director of WHO’s Global Malaria Programme. “One of the best tools we have against malaria is indoor residual house spraying. Of the dozen insecticides WHO has approved as safe for house spraying, the most effective is DDT.”

Indoor residual spraying is the application of long-acting insecticides on the walls and roofs of houses and domestic animal shelters in order to kill malaria-carrying mosquitoes that land on these surfaces.

“Indoor spraying is like providing a huge mosquito net over an entire household for around-the-clock protection,” said U.S. Senator Tom Coburn, a leading advocate for global malaria control efforts. “Finally, with WHO’s unambiguous leadership on the issue, we can put to rest the junk science and myths that have provided aid and comfort to the real enemy – mosquitoes – which threaten the lives of more than 300 million children each year.”

Views about the use of insecticides for indoor protection from malaria have been changing in recent years. Environmental Defense, which launched the anti-DDT campaign in the 1960s, now endorses the indoor use of DDT for malaria control, as does the Sierra Club and the Endangered Wildlife Trust. The recently-launched President’s Malaria Initiative (PMI) announced last year that it would also fund DDT spraying on the inside walls of households to prevent the disease.

“I anticipate that all 15 of the country programs of President Bush’s $1.2 billion commitment to cut malaria deaths in half will include substantial indoor residual spraying activities, including many that will use DDT,” said Admiral R. Timothy Ziemer, Coordinator of the President’s Malaria Initiative. “Because it is relatively inexpensive and very effective, USAID supports the spraying of homes with insecticides as a part of a balanced, comprehensive malaria prevention and treatment program. “

Programmatic evidence shows that correct and timely use of indoor residual spraying can reduce malaria transmission by up to 90 percent. In the past, India was able to use DDT effectively in indoor residual spraying to cut dramatically the number of malaria cases and fatalities. South Africa has again re-introduced DDT for indoor residual spraying to keep malaria case and fatality numbers at all-time low levels and move towards malaria elimination. Today, 14 countries in Sub-Saharan Africa are using IRS and 10 of those are using DDT.

At today’s news conference, the World Health Organization also called on all malaria control programmes around the world to develop and issue a clear statement outlining their position on indoor spraying with long-lasting insecticides such as DDT, specifying where and how spraying will be implemented in accordance with WHO guidelines, and how they will provide all possible support to accelerate and manage this intervention effectively.

“All development agencies and endemic countries need to act in accordance with WHO’s position on the use of DDT for indoor residual spraying,” said Richard Tren, Director of Africa Fighting Malaria. “Donors in particular need to help WHO provide technical and programmatic support to ensure these interventions are used properly.”

Indoor residual spraying is one of the main interventions WHO is now promoting to control and eliminate malaria globally. A second is the widespread use of insecticide-treated mosquito nets. While the use of bed nets has long been encouraged by WHO, the recent development of “long-lasting insecticidal nets” (LLINs) has dramatically improved their usefulness. Unlike their predecessors, the long-lasting nets need not be re-dipped in buckets of insecticide every six months as they remain effective for up to five years without retreatment.

Finally, for those who do ultimately become sick with malaria, more effective medicines are increasingly becoming available. Unlike previous antimalarials that have been rendered useless in many regions due to drug resistance, Artemisinin Combination Therapies (ACTs) are now recommended. These lifesaving medications are becoming more widely available throughout the world. In January of this year, WHO took stringent measures to help prevent future resistance to antimalarial medicines by banning the use of malaria monotherapy. An example of the negative consequences of drug resistance is apparent in the threat it poses to intermittent preventive treatment in pregnancy (IPTp), a crucial strategic intervention to protect pregnant women from the consequences of malaria.

Potential funding to scale up the availability of all three of these strategic interventions has dramatically increased over the past few years through the inception of the Global Fund to Fight AIDS, TB and Malaria, World Bank plans to significantly increase its funding for malaria, and the launch of the President’s Malaria Initiative.

“With serious money finally becoming available to fight malaria, it is more imperative than ever that WHO provides sound technical guidance and programme assistance to ensure timely and effective use of these resources,” said Dr Kochi.

Each year, more than 500 million people suffer from acute malaria, resulting in more than 1 million deaths. At least 86 percent of these deaths are in sub-Saharan Africa. Globally an estimated 3,000 children and infants die from malaria every day and 10,000 pregnant women die from malaria in Africa every year. Malaria disproportionately affects poor people, with almost 60 percent of malaria cases occurring among the poorest 20 percent of the world’s population.

For more information contact:

In Washington, DC:
Jim Palmer at 1 (202) 262-9823

In Geneva:
Ed Vela at +41 22 791-4550 or Shiva Murugasampillay at +41 22 791-1019

Leave a Reply

Your email address will not be published. Required fields are marked *